GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (MEX:0QBO) » Definitions » Cyclically Adjusted PB Ratio

Coloplast A/S (MEX:0QBO) Cyclically Adjusted PB Ratio : 26.70 (As of Jun. 21, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Coloplast A/S Cyclically Adjusted PB Ratio?

As of today (2024-06-21), Coloplast A/S's current share price is MXN2082.59. Coloplast A/S's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was MXN78.00. Coloplast A/S's Cyclically Adjusted PB Ratio for today is 26.70.

The historical rank and industry rank for Coloplast A/S's Cyclically Adjusted PB Ratio or its related term are showing as below:

MEX:0QBO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 20.9   Med: 28.48   Max: 43.12
Current: 24.39

During the past years, Coloplast A/S's highest Cyclically Adjusted PB Ratio was 43.12. The lowest was 20.90. And the median was 28.48.

MEX:0QBO's Cyclically Adjusted PB Ratio is ranked worse than
97.91% of 478 companies
in the Medical Devices & Instruments industry
Industry Median: 2.03 vs MEX:0QBO: 24.39

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Coloplast A/S's adjusted book value per share data for the three months ended in Mar. 2024 was MXN174.162. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN78.00 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast A/S Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Coloplast A/S's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Cyclically Adjusted PB Ratio Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.49 37.39 35.32 24.27 22.77

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.21 27.01 22.77 23.07 26.70

Competitive Comparison of Coloplast A/S's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Cyclically Adjusted PB Ratio falls into.



Coloplast A/S Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Coloplast A/S's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2082.59/78
=26.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast A/S's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Coloplast A/S's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=174.162/118.4000*118.4000
=174.162

Current CPI (Mar. 2024) = 118.4000.

Coloplast A/S Quarterly Data

Book Value per Share CPI Adj_Book
201406 60.890 99.700 72.311
201409 69.373 99.700 82.385
201412 62.625 99.400 74.596
201503 67.970 100.200 80.316
201506 64.709 100.300 76.386
201509 56.625 100.200 66.910
201512 47.796 99.800 56.704
201603 59.526 100.200 70.338
201606 59.349 100.600 69.850
201609 69.709 100.200 82.371
201612 58.033 100.300 68.506
201703 64.620 101.200 75.603
201706 63.735 101.200 74.567
201709 81.508 101.800 94.799
201712 69.258 101.300 80.949
201803 76.250 101.700 88.771
201806 75.642 102.300 87.547
201809 88.412 102.400 102.226
201812 73.158 102.100 84.837
201903 85.317 102.900 98.168
201906 81.347 102.900 93.600
201909 94.781 102.900 109.058
201912 71.874 102.900 82.701
202003 107.327 103.300 123.016
202006 104.259 103.200 119.615
202009 121.816 103.500 139.353
202012 88.131 103.400 100.916
202103 106.558 104.300 120.963
202106 104.994 105.000 118.393
202109 124.867 105.800 139.738
202112 94.019 106.600 104.426
202203 102.549 109.900 110.480
202206 97.914 113.600 102.051
202209 104.513 116.400 106.309
202212 77.212 115.900 78.877
202303 81.232 117.300 81.994
202306 72.119 116.400 73.358
202309 191.947 117.400 193.582
202312 167.077 116.700 169.511
202403 174.162 118.400 174.162

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast A/S  (MEX:0QBO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Coloplast A/S Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (MEX:0QBO) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (MEX:0QBO) Headlines

No Headlines